DCVC
SlowingFiled to raisePalo Alto, CABiotechnology, Hardware, ManufacturingLast fund filed 2026
2 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| DCVC VI Access IS | August 2026 | $5M | $5M | 1 |
| DCVC Energy & Climate IIFiled to raise in 2026, with no closing reported yet. | 2026 | $500M | $0 | 0 |
| DCVC VII | May 2025 | $800M | $654M | 91 |
| DCVC Climate Access | November 2024 | $20M | $20M | 3 |
| DCVC Bio IIIFiled to raise in 2023, with no closing reported yet. | 2023 | $400M | $0 | 0 |
| DCVC Climate Select | December 2022 | $300M | $157M | 20 |
| DCVC VI | April 2022 | $700M | $681M | 95 |
| DCVC Bio Opportunity FundFiled to raise in 2021, with no closing reported yet. | 2021 | $350M | $0 | 0 |
| DCVC Bio II | May 2020 | $350M | $350M | 33 |
| DCVC V | April 2019 | $750M | $718M | 80 |
| DCVC Bio | April 2018 | $250M | $208M | 41 |
| DCVC Opportunity Fund II | March 2016 | $144M | $144M | 38 |
| DCVC Opportunity FundFiled to raise in 2014, with no closing reported yet. | 2014 | $125M | $0 | 0 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
4 partners are named across this firm’s filings, 2 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Zachary Bogue | Slowing | Biotech & pharma, Data & analytics | 3 | 1 |
| John HamerNot on the current fund | Quiet | Food & agriculture, Biotech & pharma, Healthcare services | 9 | 0 |
| Kiersten SteadNot on the current fund | Quiet | None listed | 4 | 0 |
| Matthew Ocko | Quiet | Biotech & pharma, Enterprise software, AI & machine learning | 17 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Classified sectors of DCVC’s own portfolio companies, based on 18 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of DCVC’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| Dimension Capital | 2 | 3Scan, RECURSION PHARMACEUTICALS |
| Playground Global | 2 | Agility Robotics, Mosaic ML |
| Biomatics Capital Partners | 1 | Blue Talon Data Systems |
| Energize Ventures | 1 | Jupiter Intelligence |
| Future Ventures | 1 | Planet Labs |
| Greatpoint Ventures Innovation | 1 | MYTHIC |
| Ignition Venture Partners | 1 | Jupiter Intelligence |
| Lux Capital | 1 | 3Scan |
| Menlo Ventures | 1 | COFACTOR GENOMICS |
| MPM BioVentures | 1 | Umoja Biopharma |
| Notion Capital | 1 | Tradeshift Holdings |
| Signia Venture Partners | 1 | Fortem Technologies |
A shared board seat: a company where filings name a DCVC partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.